Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review

被引:24
|
作者
Jefferson, Tom [1 ]
Spencer, Elizabeth A. [2 ]
Brassey, Jon [3 ]
Onakpoya, Igho J. [1 ]
Rosca, Elena C. [4 ]
Pluddemann, Annette [2 ]
Evans, David H. [5 ,6 ]
Conly, John M. [7 ,8 ,9 ,10 ,11 ,12 ]
Heneghan, Carl J. [2 ]
机构
[1] Univ Oxford, Dept Continuing Educ, Rewley House,1 Wellington Sq, Oxford OX1 2JA, England
[2] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[3] Trip Database Ltd, Newport, Gwent, Wales
[4] Victor Babes Univ Med & Pharm, Timisoara, Romania
[5] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada
[6] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
[7] Univ Calgary, Dept Med, Synder Inst Chron Dis, Calgary, AB, Canada
[8] Univ Calgary, Dept Microbiol, Synder Inst Chron Dis, Calgary, AB, Canada
[9] Univ Calgary, Dept Immunol & Infect Dis, Synder Inst Chron Dis, Calgary, AB, Canada
[10] Univ Calgary, Dept Pathol & Lab Med, Synder Inst Chron Dis, Calgary, AB, Canada
[11] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada
[12] Alberta Hlth Serv, Calgary, AB, Canada
关键词
Asymptomatic cases; Levels of evidence; Presymptomatic cases; SARS-CoV-2; Transmission;
D O I
10.1016/j.cmi.2021.10.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The role of SARS-Cov-2-infected persons who develop symptoms after testing (pre-symptomatics) or not at all (asymptomatics) in the pandemic spread is unknown. Objectives: To determine infectiousness and probable contribution of asymptomatic persons (at the time of testing) to pandemic SARS-CoV-2 spread. Data sources: LitCovid, medRxiv, Google Scholar, and WHO Covid-19 databases (to 31 March 2021) and references in included studies. Study eligibility criteria: Studies with a proven or hypothesized transmission chain based either on serial PCR cycle threshold readings and/or viral culture and/or gene sequencing, with adequate follow-up. Participants: People exposed to SARS-CoV-2 within 2-14 days to index asymptomatic (at time of observation) infected individuals. Interventions: Reliability of symptom and signs was assessed within contemporary knowledge; trans-mission likelihood was assessed using adapted causality criteria. Methods: Systematic review. We contacted all included studies' corresponding authors requesting further details. Results: We included 18 studies from a diverse setting with substantial methodological variation (this field lacks standardized methodology). At initial testing, prevalence of asymptomatic cases was 12.5-100%. Of these, 6-100% were later determined to be presymptomatic, this proportion varying according to setting, methods of case ascertainment and population. Nursing/care home facilities reported high rates of presymptomatic: 50-100% (n = 3 studies). Fourteen studies were classified as high risk of, and four studies as at moderate risk of symptom ascertainment bias. High-risk studies may be less likely to distinguish between presymptomatic and asymptomatic cases. Six asymptomatic studies and four pre-symptomatic studies reported culturing infectious virus; data were too sparse to determine infectious-ness duration. Three studies provided evidence of possible and three of probable/likely asymptomatic transmission; five studies provided possible and two probable/likely presymptomatic SARS-CoV-2 transmission. Conclusion: High-quality studies provide probable evidence of SARS-CoV-2 transmission from pre-symptomatic and asymptomatic individuals, with highly variable estimated transmission rates. (C) 2021 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
引用
收藏
页码:178 / 189
页数:12
相关论文
共 50 条
  • [41] Molecular Dynamics Studies for Nirmatrelvir and the Main Protease from Variants of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
    Frey, Kathleen
    Dutta, Ongshu
    Tran, Lilian
    Yin, Brandon
    Makarus, Andrew
    Marmol, Raymond
    Dawood, Youssef
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [42] Detection of Transmissible Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Blood and Biopsies From Deceased Kidney Donors
    Azhar, Ambreen
    Khorsandi, Shiba
    Moinuddin, Irfan A.
    Molnar, Miklos Z.
    Levy, Marlon F.
    Tanriover, Bekir
    Gupta, Gaurav
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 828 - 828
  • [43] Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
    Lim, Wei Yin
    Lan, Boon Leong
    Ramakrishnan, Narayanan
    BIOSENSORS-BASEL, 2021, 11 (11):
  • [44] Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
    Grima, Alicia A.
    Murison, Kiera R.
    Simmons, Alison E.
    Tuite, Ashleigh R.
    Fisman, David N.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E409 - E415
  • [45] A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Istuti Saraswat
    Sarmistha Saha
    Anuja Mishra
    Toxicology and Environmental Health Sciences, 2023, 15 : 315 - 324
  • [46] A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Saraswat, Istuti
    Saha, Sarmistha
    Mishra, Anuja
    TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, 2023, 15 (04) : 315 - 324
  • [47] The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Davidov-Derevynko, Yana
    Ben Yakov, Gil
    Wieder, Anat
    Segal, Gad
    Naveh, Lior
    Orlova, Natalia
    Gringauz, Irina
    Amit, Sharon
    Mor, Orna
    Klempfner, Robert
    Rahav, Galia
    Ben Ari, Ziv
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E313 - E319
  • [48] Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
    Maveddat, Ashley
    Mallah, Haneen
    Rao, Sanjana
    Ali, Kiran
    Sherali, Samir
    Nugent, Kenneth
    INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 11 (04): : 157 - 178
  • [49] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunity and Reinfection
    Dan, Jennifer
    Mehta, Sanjay
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2992 - E2994
  • [50] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
    Synowiec, Aleksandra
    Szczepanski, Artur
    Barreto-Duran, Emilia
    Lie, Laurensius Kevin
    Pyrc, Krzysztof
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (02) : 1 - 32